Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Simon

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
Plos One|December 5, 2015
Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic AbnormalitiesMathilde Ghislain, Jean-Philippe Bastard, Laurence Meyer, et al.
Plos One|March 7, 2017
How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE studyGuillemette Quatremère, Marguerite Guiguet, Patricia Girardi, et al.
Hepatology International|July 16, 2011
Current management and recommendations on hepatitis B therapy in HIV-coinfected patientsLionel Piroth, Sophie Mahy, Stanislas Pol, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 2009
Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drugMarc Wirden, Anne Simon, Luminita Schneider, et al.
The FEBS Journal|January 17, 2014
Crystal structure and immunological properties of the first annexin from Schistosoma mansoni: insights into the structural integrity of the schistosomal tegumentChiuan Yee Leow, Charlene Willis, Asiah Osman, et al.
AIDS (London, England)|April 2, 2005
Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitutionMarc Wirden, Isabelle Malet, Anne Derache, et al.
AIDS (London, England)|October 4, 2008
Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patientsCathia Soulié, Isabelle Malet, Sidonie Lambert-Niclot, et al.
Diagnostic Microbiology and Infectious Disease|June 3, 2021
Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivityAnaïs Scohy, Damien Gruson, Anne Simon, et al.
AIDS (London, England)|March 3, 2006
Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitorsBénédicte Roquebert, Isabelle Malet, Marc Wirden, et al.
Journal of Hepatology|February 14, 2012
Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfectionSawsan Harfouch, Marguerite Guiguet, Marc-Antoine Valantin, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Plos One|December 5, 2015
Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic AbnormalitiesMathilde Ghislain, Jean-Philippe Bastard, Laurence Meyer, et al.
Plos One|March 7, 2017
How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE studyGuillemette Quatremère, Marguerite Guiguet, Patricia Girardi, et al.
Hepatology International|July 16, 2011
Current management and recommendations on hepatitis B therapy in HIV-coinfected patientsLionel Piroth, Sophie Mahy, Stanislas Pol, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 2009
Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drugMarc Wirden, Anne Simon, Luminita Schneider, et al.
The FEBS Journal|January 17, 2014
Crystal structure and immunological properties of the first annexin from Schistosoma mansoni: insights into the structural integrity of the schistosomal tegumentChiuan Yee Leow, Charlene Willis, Asiah Osman, et al.
AIDS (London, England)|April 2, 2005
Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitutionMarc Wirden, Isabelle Malet, Anne Derache, et al.
AIDS (London, England)|October 4, 2008
Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patientsCathia Soulié, Isabelle Malet, Sidonie Lambert-Niclot, et al.
Diagnostic Microbiology and Infectious Disease|June 3, 2021
Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivityAnaïs Scohy, Damien Gruson, Anne Simon, et al.
AIDS (London, England)|March 3, 2006
Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitorsBénédicte Roquebert, Isabelle Malet, Marc Wirden, et al.
Journal of Hepatology|February 14, 2012
Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfectionSawsan Harfouch, Marguerite Guiguet, Marc-Antoine Valantin, et al.
Pageof 17